Fresh Tracks Therapeutics, Inc. (FRTX)

0.9075 +0.0075 (+0.83%) At close: 03:57PM EDT

Fresh Tracks Therapeutics, Inc.

5777 Central Avenue
Suite 102
Boulder, CO 80301
United States
720 505 4755
https://www.frtx.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 4

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Albert Nicholas Marchio II	CEO, CFO, Secretary & Chairman	N/A	N/A	1952
Aron Aizenstat M.B.A., P.M.P.	Vice President of Corporate Development & Operations	N/A	N/A	N/A
Mr. Aaron Fox-Collis CPA	VP of Finance & Chief Accounting Officer	N/A	N/A	N/A
Ms. Sue Fattor	Head of Human Resource	N/A	N/A	N/A
Dr. James S. McElvain Ph.D.	Interim Head of CMC Development	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops FRTX-02 (BBI-02), an oral DYRK1A inhibitor that is completed Phase 1 clinical trials for the treatment of autoimmune and inflammatory diseases; FRTX-10 (BBI-10), a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases; and FRTX-03, a topical DYRK1A inhibitor for the treatment of mild-to-moderate skin conditions, as well as next-generation kinase inhibitors. Fresh Tracks Therapeutics, Inc. has license and collaboration agreements with Carna Biosciences, Inc., and Voronoi Inc. The company was formerly known as Brickell Biotech, Inc. and changed its name to Fresh Tracks Therapeutics, Inc. in September 2022. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

Corporate governance

Fresh Tracks Therapeutics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.